본문 바로가기
KERD
논문KCI 등재

Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류내과학

초록

In September 2011, the Korean Society of Hematology Lymphoma Working Party held a nationwide conference to establish a consensus for assessing bone marrow (BM) involvement in patients with lymphoma. At this conference, many clinicians, hematopathologists, and diagnostic hematologists discussed various topics for a uniform consensus in the evaluation process to determine whether the BM is involved. Now that the discussion has matured sufficiently to be published, we herein describe the consensus reached and limitations in current methods for assessing BM involvement in patients with lymphoma.

Abstract

In September 2011, the Korean Society of Hematology Lymphoma Working Party held a nationwide conference to establish a consensus for assessing bone marrow (BM) involvement in patients with lymphoma. At this conference, many clinicians, hematopathologists, and diagnostic hematologists discussed various topics for a uniform consensus in the evaluation process to determine whether the BM is involved. Now that the discussion has matured sufficiently to be published, we herein describe the consensus reached and limitations in current methods for assessing BM involvement in patients with lymphoma.

참고문헌 (40)

  1. Zhang QY, "Bone marrow involvement by hodgkin and non-hodgkin lymphomas", Hematol Oncol Clin North Am, 23, pp.873~902 (2009)
  2. Carbone PP, "Report of the committee on Hodgkin’s disease staging classification", Cancer Res, 31, pp.1860~1861 (1971)
  3. Lister TA, "Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting", J Clin Oncol, 7, pp.1630~1636 (1989)
  4. Hoppe RT, "Hodgkin lymphoma", J Natl Compr Canc Netw, 9, pp.1020~1058 (2011)
  5. Zelenetz AD, "NCCN clinical practice guidelines in oncology: non-Hodgkin’s lymphomas", J Natl Compr Canc Netw, 8, pp.288~334 (2010)
  6. Bayraktar S, "Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients", Br J Haematol, 152, pp.72~80 (2011)
  7. Oh SY, "Stage IV marginal zone B-cell lymphoma: prognostic factors and the role of rituximab. Consortium for Improving Survival of Lymphoma (CISL) study", Cancer Sci, 101, pp.2443~2447 (2010)
  8. Thieblemont C, "Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed", Blood, 95, pp.802~806 (2000)
  9. "The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma", N Engl J Med, 329, pp.987~994 (1993)
  10. Stiff PJ, "Autologous transplantation as consolidation for aggressive non-Hodgkin’s lymphoma", N Engl J Med, 369, pp.1681~1690 (2013)
  11. 윤재호, "Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients", The Korean Journal of Internal Medicine, 30(3), pp.362~371 (2015), 대한내과학회[DOI]
  12. Foucar K, "Bone Marrow Pathology" (2010), American Society for Clinical Pathology Press
  13. Rozman C, "Chronic lymphocytic leukemia", N Engl J Med, 333, pp.1052~1057 (1995)
  14. Montserrat E, "Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients", Br J Haematol, 93, pp.111~116 (1996)
  15. 전영우, "Chronic lymphocytic leukemia: a clinical review including Korean cohorts", The Korean Journal of Internal Medicine, 31(3), pp.433~443 (2016), 대한내과학회
  16. Fend F, "Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy", Pathobiology, 74, pp.133~143 (2007)
  17. Foucar K, "Diagnostic Pathology:Blood and Bone Marrow" (2012), Amirsys Pub.
  18. Brown D, "Bone Marrow Diagnosis: An Illustrated Guide" (2006), Blackwell
  19. Alizadeh AA, "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, pp.503~511 (2000)
  20. Hans CP, "Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray", Blood, 103, pp.275~282 (2004)
  21. Kremer M, "Discordant bone marrow involvement in diffuse large B-cell lymphoma:comparative molecular analysis reveals a heterogeneous group of disorders", Lab Invest, 83, pp.107~114 (2003)
  22. Howell SJ, "The value of bone marrow examination in the staging of Hodgkin’s lymphoma:a review of 955 cases seen in a regional cancer centre", Br J Haematol, 119, pp.408~411 (2002)
  23. 정소연, "세계보건기구 분류에 근거한 악성림프종의 골수침습 빈도 및 양상- 단일 기관 연구", Annals of Laboratory Medicine, 27(6), pp.383~387 (2007), 대한진단검사의학회
  24. Bartl R, "Assessment of bone marrow histology in Hodgkin’s disease: correlation with clinical factors", Br J Haematol, 51, pp.345~360 (1982)
  25. Swerdlow SH, "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues" (2008), International Agency for Research on Cancer
  26. Bene MC, "Immunophenotyping of acute leukemia and lymphoproliferative disorders:a consensus proposal of the European LeukemiaNet Work Package 10", Leukemia, 25, pp.567~574 (2011)
  27. 김지명, "한국인 비호지킨림프종의 백혈병성 골수침습에 대한 임상혈액학적 소견", Laboratory Medicine Online, 1(2), pp.81~87 (2011), 대한진단검사의학회
  28. van Dongen JJ, "EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes", Leukemia, 26, pp.1908~1975 (2012)
  29. The Korean Society of Hematology, "Hematology" (2006), Epublic
  30. Cheson BD, "Revised response criteria for malignant lymphoma", J Clin Oncol, 25, pp.579~586 (2007)
  31. Thiele J, "Focal lymphoid aggregates (nodules) in bone marrow biopsies:differentiation between benign hyperplasia and malignant lymphoma: a practical guideline", J Clin Pathol, 52, pp.294~300 (1999)
  32. Sehn LH, "Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP", J Clin Oncol, 29, pp.1452~1457 (2011)
  33. Merli M, "Assessment of bone marrow involvement in non-Hodgkin’s lymphomas : comparison between histology and flow cytometry", Eur J Haematol, 85, pp.405~415 (2010)
  34. Campbell J, "The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement", Eur J Haematol, 76, pp.473~480 (2006)
  35. Conlan MG, "Bone marrow involvement by non-Hodgkin’s lymphoma:the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group", J Clin Oncol, 8, pp.1163~1172 (1990)
  36. Morra E, "Bone marrow and blood involvement by non-Hodgkin’s lymphoma: a study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation", Eur J Haematol, 42, pp.445~453 (1989)
  37. Yan Y, "Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma", J Clin Oncol, 13, pp.1336~1342 (1995)
  38. Ribrag V, "Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET", CT and bone marrow biopsy, 2008, pp.66, 325~331
  39. Kwee TC, "Imaging of bone marrow involvement in lymphoma: state of the art and future directions", ScientificWorldJournal, 11, pp.391~402 (2011)
  40. Hanna SL, "Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy", Skeletal Radiol, 20, pp.79~84 (1991)

관련 논문AI추천

The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Lymphoma권정혜, 김정한, 김주석, 김형수, 김호영, 김화정, 김효정, 민수기, 송헌호, 이영경, 장근두, 장대영, 정주영, 최대로, 황희성대한암학회 · Cancer Research and Treatment2015 · 제47권 제3호Concordance of Current Tests Used for the Diagnosis of Bone Marrow Involvement in B-Lineage Lymphoma with Respect to Various Lymphoma Grade김인숙, 김혜림, 문슬기, 박상혁대한진단검사의학회 · Laboratory Medicine Online2023 · 제13권 제3호한국인 비호지킨림프종의 백혈병성 골수침습에 대한 임상혈액학적 소견강윤구, 김지명, 박찬정, 서종진, 장성수, 지현숙, 허주령대한진단검사의학회 · Laboratory Medicine Online2011 · 제1권 제2호Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement김확, 강병욱, 권기영, 김민경, 김여경, 김종광, 김진영, 김형준, 도영록, 류헌모, 문준호, 박건욱, 배성화, 손상균, 송홍석, 양덕환, 이경희, 이수정, 이제중, 채의수, 현명수대한암학회 · Cancer Research and Treatment2013 · 제45권 제2호세계보건기구 분류에 근거한 악성림프종의 골수침습 빈도 및 양상- 단일 기관 연구이승숙, 이진경, 장윤환, 정소연, 홍석일, 홍영준대한진단검사의학회 · Annals of Laboratory Medicine2007 · 제27권 제6호Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma김보람, 김선희, 김희진, 이승태대한진단검사의학회 · Annals of Laboratory Medicine2015 · 제35권 제2호

이 간행물의 다른 논문 (24건)